Literature DB >> 6645754

Otosyphilis and hearing loss: response to penicillin and steroid therapy.

J M Dobbin, J H Perkins.   

Abstract

Acquired and congenital syphilis are both known causes of potentially reversible sensorineural hearing loss. Various therapeutic regimens, including penicillin and/or corticosteroids have been used in the past as treatment for otosyphilis. Response rates have varied from 15% to 80%. In this retrospective study, 13 patients with otosyphilis were treated with a combined course of long-term penicillin and prednisone. A significant response was defined as a 15% improvement in the discrimination score and/or the pure tone average. Initial response rates were 35% with a lasting response rate of 15%. Discrimination scores improved more commonly than pure tone averages. No patient with congenital syphilis or profound deafness had a lasting response. An analysis of possible reasons for failure of therapy is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6645754     DOI: 10.1288/00005537-198312000-00003

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Otosyphilis and HIV: therapeutic dilemma and outcome of treatment.

Authors:  Bruce John McKenzie; J W Loock
Journal:  BMJ Case Rep       Date:  2009-10-14

2.  Stria vascularis and cochlear hair cell changes in syphilis: A human temporal bone study.

Authors:  Ömer Hızlı; Serdar Kaya; Pelin Hızlı; Michael M Paparella; Sebahattin Cureoglu
Journal:  Auris Nasus Larynx       Date:  2016-02-06       Impact factor: 1.863

3.  Pediatric otosyphilis-An unusual cause of conductive hearing loss.

Authors:  Zoya Arain; Yasmin Abbas; Ashok Adams
Journal:  Radiol Case Rep       Date:  2019-11-09

4.  A Rare Cause of Acute Bilateral Hearing Loss: Otosyphilis.

Authors:  Karim Amidou Abdul; Luis Silva; Jorge Perez
Journal:  Cureus       Date:  2020-10-29

5.  Otosyphilis with Clinical and Serologic Responses with Weekly Intramuscular Penicillin: A Case Report and Literature Review.

Authors:  Ali Etemady-Deylamy; Getahun Abate
Journal:  Case Rep Infect Dis       Date:  2022-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.